Evidence map›Paper›PMID 21509436›Full record

ArticleInternational journal of hematology2011

Lymph node-based disease and HHV-8/KSHV infection in HIV seronegative patients: report of three new cases of a heterogeneous group of diseases.

Antonio D'Antonio, Maria Addesso, Domenico Memoli, Pina Liguori, Roberto Cuomo, Amedeo Boscaino, Oscar Nappi

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Skin graft donor site: a procedure for a faster healing.Acta bio-medica : Atenei Parmensis · 2017
    Article
  11. Article
  12. Article
  13. Multicentric Castleman disease: Where are we now?Seminars in diagnostic pathology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Antonio D'AntonioUnit of Pathologic Anatomy and Oncology, A.O. "San Giovanni di Dio e Ruggi d'Aragona", via S. Leonardo, Salerno, Italy. ada66@inwind.it.
Maria AddessoUnit of Pathologic Anatomy, Hospital "Scarlato", ASL SA1, Scafati (SA), Italy.
Domenico MemoliUnit of Pathologic Anatomy and Oncology, A.O. "San Giovanni di Dio e Ruggi d'Aragona", via S. Leonardo, Salerno, Italy.
Pina LiguoriUnit Pathologic Anatomy, National Tumor Institute "Pascale", Naples, Italy.
Roberto CuomoUniversity of Medicine, Salerno, Italy.
Amedeo BoscainoUnit of Pathologic Anatomy, A.O.R.N. Hospital "Cardarelli", Naples, Italy.
Oscar NappiUnit of Pathologic Anatomy, A.O.R.N. Hospital "Cardarelli", Naples, Italy.
Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe three cases of lymph proliferative diseases characterized by the presence of lymphoma cells expressing the KSHV/HHV-8 antigen with or without EBV expression. The patients were HIV seronegative without serous effusions. One case was diagnosed as KSHV-germinotropic lymphoproliferative disorder due to the presence of atypical plasmablasts involving germinal centers. These plasmablasts were positive for MUM1 and vIL6, co-expressed EBV and LNA-1 of HHV-8/KSHV, and showed a polyclonal pattern of Ig gene rearrangements on PCR. The disease was localized and the prognosis was good. In two other cases, a diagnosis of KSHV/HHV-8-related diffuse large cell B-lymphoma morphology was made. The lymphoma cells were anaplastic or frankly pleomorphic, expressed KSHV but not EBV, and were positive for CD20, MUM1, PAX-5, and vIL6. In both cases the prognosis was poor. On the basis of the features observed, we raise three considerations: (1) KSHV-related lymphoproliferative disorders represent a distinctive and heterogeneous group of diseases with variable clinico-pathologic findings and immunophenotypes (BCL6-/MUM1+/CD138- and BCL6+/MUM1+/CD138- or BCL6-/MUM1+/CD138+). (2) Although the pathogenic mechanism of HHV8 in lymphomagenesis is unclear, the presence the viral DNA in lymph nodes of HIV- patients is not a simply opportunistic infection, but is directly implicated in the pathogenesis of KSHV-related diseases; the activation of IL-6 receptor signalling may play an important role in most cases. (3) The different prognoses among different diseases with KSHV etiology may be related to the fact that the pathogenic potential appears to be constrained by a competent immune system.

Indexed as

HIV SeronegativityAdultAgedFemaleHerpesviridae InfectionsHerpesvirus 4, HumanHerpesvirus 8, HumanHumansImmunophenotypingLymph NodesLymphoma, Large B-Cell, DiffuseLymphoproliferative DisordersMaleMiddle AgedPlasma CellsPrognosis

Identifiers

PMID21509436
OpenAlexW2087754398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.